Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.

The ability to offer SROM (in addition to buprenorphine or methadone) increased rates of OAT initiation among hospitalised patients. Increasing access to SROM would help narrow the opioid use disorder treatment gap of unmet need.